David G Kalergis
CIK 1663574 · View on SEC EDGAR ↗
First SEC filing: Jan. 30, 2020 · Latest: Jan. 30, 2020
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2020 | CRVO | A | 262,900 | — | — | 262,900 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 2, 2018 | CRVO | A | 55,000 | — | — | 55,000 Direct | — | Acquired | (price as of 2026-08-25) |
| May 10, 2017 | CRVO | A | 41,000 | — | — | 41,000 Direct | — | Acquired | (price as of 2026-08-25) |
| May 10, 2017 | CRVO | A | 41,000 | — | — | 41,000 Direct | — | Acquired | (price as of 2026-08-25) |
| Dec. 8, 2016 | CRVO | A | 105,000 | — | — | 105,000 Direct | — | Acquired | (price as of 2026-08-25) |
| May 16, 2016 | CRVO | A | 204,167 | — | — | 204,167 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 1,069,216 | — | — | 1,069,216 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 215,506 | — | — | 215,506 Indirect | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 295,865 | — | — | 295,865 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 91,316 | — | — | 91,316 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 273,949 | — | — | 273,949 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 127,843 | — | — | 127,843 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 182,632 | — | — | 182,632 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 182,632 | — | — | 182,632 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 127,843 | — | — | 127,843 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 365,265 | — | — | 365,265 Direct | — | Acquired | (price as of 2026-08-25) |
| Jan. 8, 2016 | CRVO | A | 331,595 | — | — | 331,595 Direct | — | Acquired | (price as of 2026-08-25) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 2, 2020 | CRVO | Stock Option (Right to Buy) | Common Stock (262,900) | $0.46 | Jan. 31, 2030 | 262,900 | Acquired |
| Jan. 2, 2018 | CRVO | Stock Option (Right to Buy) | Common Stock (55,000) | $1.18 | Jan. 2, 2028 | 55,000 | Acquired |
| May 10, 2017 | CRVO | Stock Option (Right to Buy) | Common Stock (41,000) | $2.96 | May 10, 2027 | 41,000 | Acquired |
| May 10, 2017 | CRVO | Stock Option (Right to Buy) | Common Stock (41,000) | $2.95 | May 10, 2027 | 41,000 | Acquired |
| Dec. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (105,000) | $2.74 | Dec. 8, 2026 | 105,000 | Acquired |
| May 16, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (204,167) | $0.96 | May 16, 2026 | 204,167 | Acquired |
| Jan. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (295,865) | $0.22 | May 17, 2022 | 295,865 | Acquired |
| Jan. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (91,316) | $0.22 | Oct. 9, 2022 | 91,316 | Acquired |
| Jan. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (273,949) | $0.22 | Oct. 9, 2022 | 273,949 | Acquired |
| Jan. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (127,843) | $0.35 | Oct. 5, 2023 | 127,843 | Acquired |
| Jan. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (182,632) | $0.62 | Oct. 5, 2023 | 182,632 | Acquired |
| Jan. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (182,632) | $0.42 | Dec. 1, 2024 | 182,632 | Acquired |
| Jan. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (127,843) | $0.42 | Dec. 1, 2024 | 127,843 | Acquired |
| Jan. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (365,265) | $0.55 | Oct. 30, 2025 | 365,265 | Acquired |
| Jan. 8, 2016 | CRVO | Stock Option (Right to Buy) | Common Stock (331,595) | $0.55 | Oct. 30, 2025 | 331,595 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $255,537 | $60,000 | — | — | — | — | $165,899 | $481,436 |
| 2019 | $410,000 | — | — | — | $50,000 | — | $15,717 | $475,717 |
| 2018 | $439,192 | — | — | $64,905 | $66,208 | — | $16,836 | $587,141 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.